Olsson H - Search Results

1

Early oral contraceptive use as a prognostic factor in breast cancer.

Olsson H, Möller TR, Ranstam J, Borg A, Fernö M. Olsson H, et al. Anticancer Res. 1988 Jan-Feb;8(1):29-32. Anticancer Res. 1988. PMID: 3358638

2

Chromosome 1 alterations in breast cancer: allelic loss on 1p and 1q is related to lymphogenic metastases and poor prognosis.

Borg A, Zhang QX, Olsson H, Wenngren E. Borg A, et al. Among authors: olsson h. Genes Chromosomes Cancer. 1992 Nov;5(4):311-20. doi: 10.1002/gcc.2870050406. Genes Chromosomes Cancer. 1992. PMID: 1283319

3

Southern travelling habits with special reference to tumour site in Swedish melanoma patients.

Westerdahl J, Olsson H, Ingvar C, Brandt L, Jönsson PE, Möller T. Westerdahl J, et al. Among authors: olsson h. Anticancer Res. 1992 Sep-Oct;12(5):1539-42. Anticancer Res. 1992. PMID: 1444218

4

Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry.

Baldetorp B, Fernö M, Fallenius A, Fallenius-Vecchi G, Idvall I, Olsson H, Sigurdsson H, Akerman M, Killander D. Baldetorp B, et al. Among authors: olsson h. Cytometry. 1992;13(6):577-85. doi: 10.1002/cyto.990130605. Cytometry. 1992. PMID: 1451590 Free article.

5

Plasma prolactin in relation to menstrual cycle phase, oral contraceptive use, arousal time and smoking habits.

Jernström H, Knutsson M, Taskila P, Olsson H. Jernström H, et al. Among authors: olsson h. Contraception. 1992 Dec;46(6):543-8. doi: 10.1016/0010-7824(92)90119-e. Contraception. 1992. PMID: 1493714

6

One or multiple samplings for flow cytometric DNA analyses in breast cancer-prognostic implications?

Fernö M, Baldetorp B, Ewers SB, Idvall I, Olsson H, Sigurdsson H, Killander D. Fernö M, et al. Among authors: olsson h. Cytometry. 1992;13(3):241-9. doi: 10.1002/cyto.990130305. Cytometry. 1992. PMID: 1576890 Free article.

7

The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression.

Borg A, Zhang QX, Alm P, Olsson H, Sellberg G. Borg A, et al. Among authors: olsson h. Cancer Res. 1992 May 15;52(10):2991-4. Cancer Res. 1992. PMID: 1581913

8

c-myc amplification is an independent prognostic factor in postmenopausal breast cancer.

Borg A, Baldetorp B, Fernö M, Olsson H, Sigurdsson H. Borg A, et al. Among authors: olsson h. Int J Cancer. 1992 Jul 9;51(5):687-91. doi: 10.1002/ijc.2910510504. Int J Cancer. 1992. PMID: 1612775

9

Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome.

Fernö M, Baldetorp B, Borg A, Olsson H, Sigurdsson H, Killander D. Fernö M, et al. Among authors: olsson h. Acta Oncol. 1992;31(2):157-65. doi: 10.3109/02841869209088897. Acta Oncol. 1992. PMID: 1622630

10

ERBB2 amplification in breast cancer with a high rate of proliferation.

Borg A, Baldetorp B, Fernö M, Killander D, Olsson H, Sigurdsson H. Borg A, et al. Among authors: olsson h. Oncogene. 1991 Jan;6(1):137-43. Oncogene. 1991. PMID: 1671531

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

888 results

Search Page

Filters